Literature DB >> 9144740

Evaluation of renal tubular secretion and reabsorption of levofloxacin in rats.

I Yano1, T Ito, M Takano, K Inui.   

Abstract

PURPOSE: Levofloxacin, a quinolone antibacterial drug, is a zwitterion at physiological pH. We examined the effect of cationic and anionic drugs on renal excretion of levofloxacin by means of in vivo clearance to characterize the mechanisms of renal excretion of this drug.
METHODS: In vivo clearance was studied in male Wistar albino rats. A bolus dose of 2.85 mg/kg of levofloxacin was administered, followed by a constant infusion of 7.08 micrograms/min. Cimetidine, tetraethylammonium, or p-aminohippurate was administered as a bolus and incorporated into the infusion solution. After reaching steady state, urine and blood concentrations were measured, and pharmacokinetic parameters were calculated.
RESULTS: Renal clearance was 2.56 +/- 0.42 ml/min in control, which accounted for 34% of the total body clearance. Renal clearance was significantly decreased to 0.83 +/- 0.25 ml/min by cimetidine (p < .05), corresponding to 32% of the control value. The cationic drug, tetraethyl-ammonium also reduced the renal clearance of levofloxacin, but the effect of the anionic drug, p-aminohippurate, was slight. The clearance ratio of levofloxacin, which was calculated by renal clearance divided by the plasma unbound fraction and the glomerular filtration rate, was 1.60 +/- 0.38 in the control and it was decreased to 0.68 +/- 0.17 and 1.11 +/- 0.22 by cimetidine and tetraethylammonium, respectively.
CONCLUSIONS: The present results suggest that the renal excretion of levofloxacin in rats involves tubular secretion and reabsorption, in addition to glomerular filtration, and that tubular secretion is inhibited by cimetidine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144740     DOI: 10.1023/a:1012111902798

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  A new spectrophotometric method for the detection and determination of keto sugars and trioses.

Authors:  Z DISCHE; E BORENFREUND
Journal:  J Biol Chem       Date:  1951-10       Impact factor: 5.157

2.  Transport of levofloxacin in a kidney epithelial cell line, LLC-PK1: interaction with organic cation transporters in apical and basolateral membranes.

Authors:  T Ohtomo; H Saito; N Inotsume; M Yasuhara; K I Inui
Journal:  J Pharmacol Exp Ther       Date:  1996-03       Impact factor: 4.030

3.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  J Histochem Cytochem       Date:  1989-02       Impact factor: 2.479

5.  Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs.

Authors:  T Ooie; H Suzuki; T Terasaki; Y Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

6.  Interaction of ofloxacin with organic cation transport system in rat renal brush-border membranes.

Authors:  T Okano; H Maegawa; K Inui; R Hori
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

7.  Bisubstrates: substances that interact with both, renal contraluminal organic anion and organic cation transport systems. II. Zwitterionic substrates: dipeptides, cephalosporins, quinolone-carboxylate gyrase inhibitors and phosphamide thiazine carboxylates; nonionizable substrates: steroid hormones and cyclophosphamides.

Authors:  K J Ullrich; G Rumrich; C David; G Fritzsch
Journal:  Pflugers Arch       Date:  1993-11       Impact factor: 3.657

Review 8.  Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions.

Authors:  F Sörgel; M Kinzig
Journal:  Am J Med       Date:  1993-03-22       Impact factor: 4.965

9.  Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacin.

Authors:  P M Misiak; M A Eldon; R D Toothaker; A J Sedman
Journal:  J Clin Pharmacol       Date:  1993-01       Impact factor: 3.126

10.  Renal excretion of cimetidine.

Authors:  I M Weiner; L Roth
Journal:  J Pharmacol Exp Ther       Date:  1981-03       Impact factor: 4.030

View more
  6 in total

1.  Distribution characteristics of levofloxacin and grepafloxacin in rat kidney.

Authors:  T Ito; I Yano; S Masuda; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

Review 2.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

3.  Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances.

Authors:  Larry A Bauer; Douglas J Black; Jennifer S Lill; Julie Garrison; Vidmantas A Raisys; Thomas M Hooton
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis.

Authors:  Yuji Sakurai; Hideyuki Motohashi; Ken Ogasawara; Tomohiro Terada; Satohiro Masuda; Toshiya Katsura; Noriko Mori; Motokazu Matsuura; Toshio Doi; Atsushi Fukatsu; Ken-ichi Inui
Journal:  Pharm Res       Date:  2005-11-01       Impact factor: 4.200

5.  Shiga-like toxin II derived from Escherichia coli O157:H7 modifies renal handling of levofloxacin in rats.

Authors:  Ying Lan Zhao; Xiao Bo Cen; Masafumi Ito; Keiko Yokoyama; Kenji Takagi; Kiyoyuki Kitaichi; Masayuki Nadai; Michio Ohta; Kenzo Takagi; Takaaki Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

6.  Transepithelial transport of levofloxacin in the isolated perfused rat kidney.

Authors:  T Ito; I Yano; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.